Recent 8-K filings for PMVP

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 12:00 UTC earnings item 2.02item 9.01

  PMV Pharma Q1 net loss $18M; rezatapopt NDA for ovarian cancer targeted for Q1 2027

source · PMVP on sec.gov